Skip to main content
. 2022 Dec 27;59(1):58. doi: 10.3390/medicina59010058

Table 1.

General characteristics of the patients included in the study.

Characteristics Patients (n = 151)
Women, n (%) 101 (66.9)
Age, mean (SD) 66.3 (16.5)
BMI, mean (SD) 25.8 (4.8)
Current smoking, n (%) 14 (9.3)
Previous (>1 year) foot or ankle surgery, n (%) 15 (9.9)
Use of foot orthoses, n (%) 11 (7.3)
Foot pain lasting > 3 months, n (%) 76 (50.3)
Use of paracetamol or NSAIDs, n (%) 40 (26.5)
FSDC ≥ 13, n (%) 21 (13.9)
Chief complaint
Callus, n (%) 81 (53.6)
Ingrown nail, n (%) 43 (28.5)
Other, n (%) 27 (17.9)
Main involved area
Toes, n (%) 46 (30.5)
Nails, n (%) 41 (27.2)
Forefoot, n (%) 39 (25.8)
Other, n (%) 25 (16.5)
Comorbidities
Diabetes, n (%) 29 (19.2)
Hypertension, n (%) 13 (8.6)
Peripheral neuropathy, n (%) 8 (5.3)
History of stroke, n (%) 2 (1.3)
History of cancer, n (%) 8 (5.3)
Chronic kidney disease, n (%) 2 (1.3)
Osteoporosis, n (%) 22 (14.6)
Rheumatoid arthritis, n (%) 9 (6)
FFI
FFI total score, mean (SD) 54.6 (20.9)
FFI pain score, mean (SD) 60.3 (21.8)
FFI disability score, mean (SD) 59.1 (26.3)
FFI activity limitation score, mean (SD) 31.3 (22.4)

BMI: body mass index; FFI: foot function index; FSDC: fibromyalgia survey diagnostic criteria; SD: standard deviation.